4//SEC Filing
Cassella James V 4
Accession 0001209191-23-005620
CIK 0001367920other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:28 AM ET
Size
5.5 KB
Accession
0001209191-23-005620
Insider Transaction Report
Form 4
Cassella James V
Chief Development Officer
Transactions
- Sale
Common Stock
2023-01-30$8.35/sh−10,106$84,385→ 176,823 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2022.
- [F2]These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.34 to $8.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001353528
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 8:28 AM ET
- Size
- 5.5 KB